-
Chloroquine in Translational Research: Mechanistic Innova...
2025-10-24
Explore the emerging strategic opportunities for Chloroquine (N4-(7-chloroquinolin-4-yl)-N1,N1-diethylpentane-1,4-diamine) in translational research. This thought-leadership article brings together mechanistic insights, experimental validation, and competitive perspectives—empowering scientists to leverage Chloroquine as an autophagy and Toll-like receptor inhibitor in malaria, rheumatoid arthritis, and host-pathogen interaction studies. Drawing on recent breakthroughs—such as the identification of universal virulence factors in Toxoplasma gondii and the crosstalk between ubiquitin–proteasome and autophagy pathways—this piece offers actionable guidance for designing impactful, next-generation research.
-
Dextrose (D-glucose): Unlocking Immunometabolic Dynamics ...
2025-10-23
Explore the pivotal role of Dextrose (D-glucose) as a simple sugar monosaccharide in advanced glucose metabolism research, with a unique focus on its impact on immunometabolism and the tumor microenvironment. This in-depth analysis reveals mechanisms, experimental strategies, and future directions that set this cornerstone reagent apart.
-
SR-202: Selective PPARγ Antagonist for Immunometabolic Re...
2025-10-22
SR-202 (PPAR antagonist) enables precise dissection of the PPAR signaling pathway, offering unique advantages for insulin resistance, obesity, and immunometabolic disease research. Its selective nuclear receptor inhibition empowers advanced protocols in adipocyte differentiation, macrophage polarization, and translational drug development.
-
TAK-242: Advancing TLR4 Inhibition for Translational Immu...
2025-10-21
Explore TAK-242, a selective TLR4 inhibitor, as a transformative tool for dissecting innate-adaptive immune crosstalk, translational immunology, and neuropsychiatric disorder models. This article delivers an advanced, application-focused analysis unavailable elsewhere.
79 records 6/6 page Previous First page 上5页 6